Dr. Denise Jean Freidel, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 N Morley St Ste A, Moberly, MO 65270 Phone: 660-263-1225 Fax: 660-263-1255 |
Dr. Andrew Bennett Wright, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 N Morley St, Moberly, MO 65270 Phone: 573-406-5888 Fax: 660-372-9596 |
Jon P Rampton, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Union Ave, Moberly, MO 65270 Phone: 660-263-4770 |
Janet Baxter, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1600 N Morley St, Moberly, MO 65270 Phone: 660-263-1225 |
Dr. Heather Marie Gessling, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 Union Ave, Suite A And B, Moberly, MO 65270 Phone: 660-263-9095 Fax: 660-263-2228 |
Dr. Thomas A Bragg, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2100 Silva Ln, Suite A, Moberly, MO 65270 Phone: 660-263-7201 Fax: 660-263-2260 |
Philip Stitzer, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Union Ave, Suite C & D, Moberly, MO 65270 Phone: 660-263-4770 Fax: 660-263-2228 |
Katy Farber Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1501 Union Ave, Suite A & B, Moberly, MO 65270 Phone: 660-263-5556 Fax: 660-263-0054 |
Randy A Foster, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 N Morley St, Suite G, Moberly, MO 65270 Phone: 660-263-1513 |
Forest Reginald Conley, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1600 N Morley St, Moberly, MO 65270 Phone: 660-372-9595 Fax: 660-372-9596 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Protox Therapeutics Inc., a leader in the development of receptor targeted therapeutic fusion proteins, today released financial results for the third quarter, ended September 30, 2010.
Advanced Bionics (AB), the global leader in cochlear implant technology, announced today that it received approval in Europe for Neptune, the world's first and only swimmable, waterproof sound processor.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.
› Verified 4 days ago